PR Newswire

Delscience
Spotlights
Company news: QLT's full-year 2008 results PDF Print E-mail

 

QLT, Inc. first decision in 2008 was to enhance shareholder value by selling primary assets, including Eligard(R) - product line for prostate cancer -, Aczone(TM) - product for the treatment of acne - and Atrigel(R) drug delivery system.

As part of its strategic restructuring plan, the company planned to focus its business on its Visudyne(R) line - verteporfin for the treatment of wet age-related macular degeneration -, its Photodynamic therapy dermatology technology and its punctal plug delivery technology.

According to a spoken person, the company is "excited to embark on a new chapter as an ophthalmology-focused" one.

 

 
Emerging companies: NanoMedical Systems, Inc. PDF Print E-mail

 

NanoMedical Systems (NMS) is a new drug delivery device company, founded in late 2007 by Mauro Ferrari, Randy Goodall and Dave Saathoff. The company aims to commercialize the nanochannel drug delivery system developed by Dr. Mauro Ferrari and licensed through UT Health Science Center in Houston (URHSC-H). Dr. Ferrari is a professor at URHSC-H, MD Anderson and Rice University and holds a seat on the NMS Board of Directors.

 

 
<< Start < Prev 1 2 3 Next > End >>

Results 1 - 6 of 15


FAQ . Copyright 2007. Sitemap . Privacy policy